张韬
职 称：
办公电话：
电子邮件：
个人简介
张韬，主任医师、教授，博士生导师，国家临床重点专科（心脏大血管）学术带头人、血管稳态与重构国家重点实验室PI、北大上海临港国际科创中心智慧健康工程中心主任，长期致力于主动脉疾病临床诊疗与科研创新，推动“医研协同+医工融合+医智驱动”体系建设，形成了“临床发现-科研验证-转化应用-规范推广”创新范式。主持国家重点研发计划、国家自然科学基金、首都临床特色应用技术、北京自然科学基金等20余课题；累计发表学术论文81篇，总影响因子309.3，累计引用1200余次，其中第一/通讯作者在Circulation、Circ Res、Adv Sci、EBioMedicine、Theranostics 等期刊 SCI 论文 31 篇，被权威杂志 Circ Res “Meet the First Author”专栏介绍；授权专利22项，5项获专利奖，成果转化超百万元；主/参编“十四五”重点图书15部，执笔专家共识7项，被AHA、ESC和JSVS等国际指南引用。获2025北京市科技进步奖二等奖（排名1）、2020 中华医学科技奖二等奖（排名2）、2019华夏医学科技奖二等奖（排名2）、2018北京医学科技奖二等奖（排名3）、北京大学临床科学家、北京大学杰出青年医师等荣誉。任中国医师协会血管外科分会、国家心血管病专委会血管外科委员会、中国微循环协会血管疾病委员会、中国医药教育协会副主任委员；受聘《中华外科杂志》《中华胸心血管外科杂志》,《中华血管外科杂志》,《中华老年心脑血管病杂志》和《Front Cardiovasc Med》,《BJP》杂志编委和Guest Associate Editor。
所授课程
本科教学课程
《血管介入基础技术培训课程》（主讲人）
《血管疾病概述》（主讲人）
《人体解剖生理学》（参讲人）
《腹痛相关的临床、基础知识》（参讲人）
研究生课程
外科临床中的血管技术理论与实践（主讲人）
代表性论文
1. Fan Linwei, Tang Yuanjun, Liu Jian, Liu Yueqi, Xu Yiwei, Liu Jiayu, Liu Han, Pang Wei, Guo Yuxuan, Yao Weijuan, Zhang Tao#, Peng Qin, Zhou Jing; Mechanical Activation of cPLA2 Impedes Fatty Acid β-Oxidation in Vein Grafts; Advanced Science; 2025,12(3):e2411559.
2. Zhang Xuelin, Che Yang, Mao Lin, Li Dandan, Deng Jianqing, Guo Yilong, Zhao Quanyi, Zhang Xingzhong, Wang Li, Gao Xiang, Chen Yinan, Zhang Tao#; H3.3B controls aortic dissection progression by regulating vascular smooth muscle cells phenotypic transition and vascular inflammation; Genomics; 2023,115(5):110685.
3. Chen Yinan, Zhang Tao*, Yao Fang, Gao Xiang, Li Dandan, Fu Shufang, Mao Lin, Liu Fei, Zhang Xuelin, Xu Yongle, Deng Jianqing, Li Weihao, Fan Guangpu, Xiao Cangsong, Chen Yu, Wang Li, Guo Wei, Zhou Bingying; Dysregulation of interaction between LOXhigh fibroblast and smooth muscle cells contributes to the pathogenesis of aortic dissection; Theranostics; 2022,12(2):910-928.
4. Qiu Tao, Zhang Tao*, Liu Lei, Li Wei, Li Qingle, Zhang Xuemin, Jiao Yang, Li Weihao, Ma Haocheng, Zhang Xiaoming; The anatomic distribution and pulmonary embolism complications of hospital-acquired lower extremity deep venous thrombosis; Journal of Vascular Surgery: Venous and Lymphatic Disorders; 2021,9(6):1391-1398.e3.
5. Lian Guan, Li Xiaopeng, Zhang Linqi, Zhang Yangming, Sun Lulu, Zhang Xiujun, Liu Huiying, Pang Yanli, Kong Wei, Zhang Tao#, Wang Xian, Jiang Changtao; Macrophage metabolic reprogramming aggravates aortic dissection through the HIF1α-ADAM17 pathway; EBioMedicine; 2019,49:291-304.
6. Tang Run-Ze, Zhu Juan-Juan, Yang Fang-Fang, Zhang Yun-Peng, Xie Si-An, Liu Yue-Feng, Yao Wei-Juan, Pang Wei, Han Li-Li, Kong Wei, Wang Ying-Xiao, Zhang Tao#, Zhou Jing; DNA methyltransferase 1 and Kruppel-like factor 4 axis regulates macrophage inflammation and atherosclerosis; Journal of Molecular and Cellular Cardiology; 2019,128:11-24.
7. Yuan Xinli, Zhang Tao*, Yao Fang, Liao Yingnan, Liu Fei, Ren Zongna, Han Leng, Diao Lixia, Li Yankui, Zhou Bingying, He Fan, Wang Li; THO complex–dependent posttranscriptional control contributes to vascular smooth muscle cell fate decision; Circulation Research; 2018,123:538-549.
8. Zhang Tao*, Zhang Xiaoming, Yu Weidong, Chen Jian, Li Qingle, Jiao Yang, He Peiying, Shen Chenyang; Effects of chemokine-like factor 1 on vascular smooth muscle cell migration and proliferation in vascular inflammation; Atherosclerosis; 2013,226:49-57.
9. Zhang Tao*, Zhang Xiaoming, Zhang Xuemin, Jiang Jingjun, Chen Jian, Zhou Bingying; Management of multiple embolization arising from atrial myxoma; Annals of Thoracic Surgery; 2012,94:646-649.
10. Liu X, Zhang T*, Zhuang X, et al. Takayasu's Arteritis: Features and Management of 216 Patients in China[J]. ARTHRITIS AND RHEUMATISM. 2012, 64S(10): S1005-S1006.